Cerebral vasodilating capacity during forebrain ischemia: Effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase

NeuroReport

Volumn 9, Issue 14, 1998, Pages 3285-3291

  Pelligrino, Dale A ^a   Santizo, Roberto ^a   Baughman, Verna L ^a   Wang, Qiong ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

17 Estradiol; Ca2+ dependent nitric oxide synthase; Cerebral blood flow; EEG; Female rat; Ovariectomy

Indexed keywords

ARL 17477; ESTRADIOL; ESTROGEN; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; ESTROGEN BLOOD LEVEL; FEMALE; FOREBRAIN; HISTOPATHOLOGY; MEAN ARTERIAL PRESSURE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0032487513     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199810050-00026     Document Type: Article

References (25)

1. Hall ED, Pazara KE and Linseman KL. J Cerebr Blood Flow Metab 11, 292-298 (1991).
2. Hurn PD, Littleton-Kearney MT, Kirsch JR et al. J Cerebr Blood Flow Metab 15, 666-672 (1995).
3. Simpkins JW, Rajakamar G, Zhang YQ et al. J Neurosurg 87, 724-730 (1997).
4. Bell DR, Rensberger HJ, Koritnik DR et al. Am J Physiol 268, H377-H383 (1995).
5. Hayashi T, Ishikawa T, Yamada K et al. Biochem Biophys Res Commun 203, 1013-1019 (1994).
6. Pelligrino DA, Wang Q and Baughman VL. J Cerebr Blood Flow Metab 17 (Suppl. 1), S393 (1997).
7. Skarsgard P, Vanbreemen C and Laher I. Am J Physiol 273, H2248-H2256 (1997).
8. Pelligrino DA, Baughman VL and Koenig HM. Int Anesthesiol Clin 34, 113-132 (1996).
9. Hoffman WE, Pelligrino D, Werner C et al. Anesthesiology 76, 755-762 (1992).
10. Pelligrino DA, Gay RL, Baughman VL et al. Am J Physiol 271, H990-995 (1996).
11. Pelligrino DA, Miletich DJ and Albrecht RF. Am J Physiol 262, E447-E454 (1992).
12. Wang Q, Pelligrino DA, Baughman VL et al. J Cerebr Blood Flow Metab 15, 774-778 (1995).
13. Huang ZH, Huang PL, Panahian N et al. Science 265, 1883-1885 (1994).
14. Lo EH, Hara H, Rogowska J et al. Stroke 27, 1381-1385 (1996).
15. Jones SC and Radinsky CR. Soc Neurosci Abstr 23, 1572 (1997).
16. Toyoda K, Fujii K, Ibayashi S et al. J Cerebr Blood Flow Metab 17, 1089-1096 (1997).
17. Diesen SP, Moller A, Mordvincev PI et al. Acta Neurol Scand 95, 219-224 (1997).
18. Bolego C, Cignarella A, Ruzza R et al. Life Sci 60, 2291-2302 (1997).
19. Chu ZM and Beilin LJ. Clin Exp Pharmacol Physiol 24, 430-432 (1997).
20. Alkayed NJ, Harukuni I, Kimes AS et al. Stroke 29, 159-165 (1998).
21. Caulinglaser T, Watson CA, Pardi R et al. J Clin Invest 98, 36-42 (1996).
22. Green PS, Gordon K and Simpkins JW. J Steroid Biochem Mol Biol 63, 229-235 (1997).
23. Mattson MP, Robinson N and Guo Q. NeuroReport 8, 3817-3821 (1997).
24. Sohrabji F, Miranda RCG and Toranallerand CD. Proc Natl Acad Sci USA 92, 11110-11114 (1995).
25. Pelligrino DA, Baughman VL and Wang Q. Soc Neurosci Abstr 23, 1835 (1997).